Evidence map›Paper›PMID 35101160›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2022

Mouse Behavior in the Open-field Test after Meloxicam Administration.

Ana Tfb Antiorio, Jilma Alemán-Laporte, Dennis A Zanatto, Marco A A Pereira, Mariana Sag Gomes, Danilo Wadt, Pedro K Yamamoto, Maria M Bernardi, Claudia Mc Mori

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Behavioral Assessment of Tramadol and Meloxicam Effects on Postoperative Pain in a Rat Craniotomy Model.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ana Tfb AntiorioDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil;, Email: ana.tbrasil@gmail.com.
Jilma Alemán-LaporteDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil; Laboratory of Teaching in Surgery and Cancer, University of Costa Rica, San Jose, Costa Rica.
Dennis A ZanattoDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Marco A A PereiraDepartment of Surgery. School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Mariana Sag GomesDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Danilo WadtDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Pedro K YamamotoDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Maria M BernardiGraduate Program in Environmental and Experimental Pathology, Paulista University, São Paulo, Brazil.
Claudia Mc MoriDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRUniversidade Paulista · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several analgesics are suggested for pain management in mice. Nonsteroidal antiinflammatories (NSAIDs), such as meloxicam can be administered for the treatment of inflammation and acute pain; however, several side effects can occur which include gastrointestinal ulceration and renal and hepatic toxicity. We previously performed a pilot study to test the antinociceptive activity of meloxicam in mice, but we observed behavioral changes in unoperated control mice. These observations spurred further investigation. One hypothesis for the result was potential differences in formulation between commercial brands of meloxicam. Thus, this current study aimed to evaluate the effects of 3 different commercial brands of meloxicam (20 mg/kg) in the general activity of mice using the open field test. Our results showed that meloxicam had several effects on mouse behavior and caused the formation of skin lesions at the injection site, depending on the brand of the drug. The most significant adverse effect observed was decreased exploratory activity. Grooming frequency was reduced in all groups. These adverse effects might be related to the quality of the drugs because meloxicam formulations can contain crystal polymorphisms that affect drug quality and efficacy. This study points out the importance of drug quality variation that can affect the outcome of behavioral studies in mice.

Indexed as

Open Field TestThiazinesAnalgesicsAnimalsAnti-Inflammatory Agents, Non-SteroidalMeloxicamMicePilot ProjectsAnalgesicsAnti-Inflammatory Agents, Non-SteroidalMeloxicamThiazines

Identifiers

PMID35101160
PMCPMC9137284
OpenAlexW4210604487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.